Citius Pharmaceuticals, Inc. (CTXR)
Nasdaq: CTXR · CIK 0001506251 · United States
Every official Citius Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open CTXR filings
Citius Pharmaceuticals, Inc. documents
- Citius Pharmaceuticals, Inc. 10-K 2026CTXR 10-K 2026: annual report for fiscal 2026
- Citius Pharmaceuticals, Inc. 10-K 2025CTXR 10-K 2025: annual report for fiscal 2025
- Citius Pharmaceuticals, Inc. 10-K 2024CTXR 10-K 2024: annual report for fiscal 2024
- Citius Pharmaceuticals, Inc. 10-K 2023CTXR 10-K 2023: annual report for fiscal 2023
- Citius Pharmaceuticals, Inc. 10-K 2022CTXR 10-K 2022: annual report for fiscal 2022
- Citius Pharmaceuticals, Inc. 10-Q 2026CTXR 10-Q 2026: quarterly report for fiscal 2026
- Citius Pharmaceuticals, Inc. 10-Q 2025CTXR 10-Q 2025: quarterly report for fiscal 2025
- Citius Pharmaceuticals, Inc. 10-Q 2024CTXR 10-Q 2024: quarterly report for fiscal 2024
- Citius Pharmaceuticals, Inc. 10-Q 2023CTXR 10-Q 2023: quarterly report for fiscal 2023
- Citius Pharmaceuticals, Inc. 10-Q 2022CTXR 10-Q 2022: quarterly report for fiscal 2022
- Citius Pharmaceuticals, Inc. 8-K 2026CTXR 8-K 2026: current report for fiscal 2026
- Citius Pharmaceuticals, Inc. 8-K 2025CTXR 8-K 2025: current report for fiscal 2025
- Citius Pharmaceuticals, Inc. 8-K 2024CTXR 8-K 2024: current report for fiscal 2024
- Citius Pharmaceuticals, Inc. 8-K 2023CTXR 8-K 2023: current report for fiscal 2023
- Citius Pharmaceuticals, Inc. 8-K 2022CTXR 8-K 2022: current report for fiscal 2022
- Citius Pharmaceuticals, Inc. DEF 14A 2026CTXR DEF 14A 2026: proxy statement for fiscal 2026
- Citius Pharmaceuticals, Inc. DEF 14A 2025CTXR DEF 14A 2025: proxy statement for fiscal 2025
- Citius Pharmaceuticals, Inc. DEF 14A 2024CTXR DEF 14A 2024: proxy statement for fiscal 2024
- Citius Pharmaceuticals, Inc. DEF 14A 2023CTXR DEF 14A 2023: proxy statement for fiscal 2023
- Citius Pharmaceuticals, Inc. DEF 14A 2022CTXR DEF 14A 2022: proxy statement for fiscal 2022
- Citius Pharmaceuticals, Inc. Form 4 2026CTXR Form 4 2026: insider trading filing for fiscal 2026
- Citius Pharmaceuticals, Inc. Form 4 2025CTXR Form 4 2025: insider trading filing for fiscal 2025
- Citius Pharmaceuticals, Inc. Form 4 2024CTXR Form 4 2024: insider trading filing for fiscal 2024
- Citius Pharmaceuticals, Inc. Form 4 2023CTXR Form 4 2023: insider trading filing for fiscal 2023
- Citius Pharmaceuticals, Inc. Form 4 2022CTXR Form 4 2022: insider trading filing for fiscal 2022
- Citius Pharmaceuticals, Inc. S-1 2026CTXR S-1 2026: registration statement for fiscal 2026
- Citius Pharmaceuticals, Inc. S-1 2025CTXR S-1 2025: registration statement for fiscal 2025
- Citius Pharmaceuticals, Inc. S-1 2024CTXR S-1 2024: registration statement for fiscal 2024
- Citius Pharmaceuticals, Inc. S-1 2023CTXR S-1 2023: registration statement for fiscal 2023
- Citius Pharmaceuticals, Inc. S-1 2022CTXR S-1 2022: registration statement for fiscal 2022
- Citius Pharmaceuticals, Inc. 13F 2026CTXR 13F 2026: institutional holdings for fiscal 2026
- Citius Pharmaceuticals, Inc. 13F 2025CTXR 13F 2025: institutional holdings for fiscal 2025
- Citius Pharmaceuticals, Inc. 13F 2024CTXR 13F 2024: institutional holdings for fiscal 2024
- Citius Pharmaceuticals, Inc. 13F 2023CTXR 13F 2023: institutional holdings for fiscal 2023
- Citius Pharmaceuticals, Inc. 13F 2022CTXR 13F 2022: institutional holdings for fiscal 2022
More companies